Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bart Rijnders, MD, PhD
Erasmus Medical Center
Principal Investigator - David Roberts, MD, PhD
NHS Blood and Transplant, Oxford, United Kingdom
Principal Investigator - Eric Toussirot, MD, PhD
Rheumatology department, CHU Besançon, France
Principal Investigator - Hubert Schrezenmeier, MD, PhD
German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen
Principal Investigator - Lise Estcourt, MD, PhD
NHS Blood and Transplant, Oxford, United Kingdom
Principal Investigator - Pierre Tiberghien, MD, PhD
Etablissement Français du Sang, La Plaine Saint-Denis, France
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Besançon
Besançon, France
- Stauferklinikum Schwäbisch Gmünd
Mutlangen, Baden-Wurttemberg, Germany
- Diakonie-Klinikum Stuttgart
Stuttgart, Baden-Wurttemberg, Germany
- Klinikum Stuttgart
Stuttgart, Baden-Wurttemberg, Germany
- Uniklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany
- Institut Für Klinische Transfusionsmedizin (ikt)
Ulm, Baden-Wurttemberg, Germany
- Uniklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
- Universitätsklinikum Brandenburg
Brandenburg an der Havel, Brandenburg, Germany
- Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, Germany
- Elblandkliniken Riesa
Riesa, Saxony, Germany
- Charité Medizinische Klinik Iv
Berlin, Germany
- Klinikum Chemnitz Ggmbh
Chemnitz, Germany
- Erasmus Medical Center
Rotterdam, Netherlands
- Nhs Blood and Transplant
Oxford, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2022
- Primary completion
- 18 Jan 2024
- Completion
- 17 Jun 2024
- Last update posted
- 29 Oct 2024
- Registered enrollment
- 120
- Registry id
- NCT05271929
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.